Yoji Murakami Selected Research

Blood Coagulation Disorders

1/2017	Aeromonas sobria serine protease (ASP): a subtilisin family endopeptidase with multiple virulence activities.
10/2012	Inhibition of Aeromonas sobria serine protease (ASP) by α2-macroglobulin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoji Murakami Research Topics

Disease

5	Neoplasms (Cancer) 12/2021 - 04/2013
4	Renal Cell Carcinoma (Grawitz Tumor) 05/2022 - 04/2015
3	Sepsis (Septicemia) 01/2017 - 10/2012
2	Disseminated Intravascular Coagulation 01/2017 - 11/2012
2	Blood Coagulation Disorders 01/2017 - 10/2012
1	Hypertension (High Blood Pressure) 07/2022
1	Hydronephrosis 07/2022
1	Hematoma 07/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 05/2022
1	Cellulitis 03/2020
1	Diarrhea 01/2017
1	Gastroenteritis 01/2017
1	Suppuration 01/2017
1	Purpura 11/2012
1	Prostatic Neoplasms (Prostate Cancer) 11/2012
1	Anemia 11/2012
1	Hemorrhage 11/2012
1	Shock 10/2012
1	Staphylococcal Infections 03/2011

Drug/Important Bio-Agent (IBA)

3	Fibrinogen (Factor I)FDA Link 01/2017 - 03/2011
3	Serine Proteases (Serine Protease)IBA 01/2017 - 10/2012
2	Peptides (Polypeptides)IBA 03/2020 - 10/2014
2	AnaphylatoxinsIBA 10/2014 - 04/2013
2	Blood Proteins (Serum Proteins)IBA 10/2012 - 10/2012
1	HolmiumIBA 07/2022
1	yttrium-aluminum-garnetIBA 07/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 07/2022
1	TOR Serine-Threonine KinasesIBA 05/2022
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 05/2022
1	ParaffinIBA 12/2021
1	pembrolizumabIBA 12/2021
1	VaccinesIBA 03/2020
1	Immune Checkpoint InhibitorsIBA 03/2020
1	NivolumabIBA 03/2020
1	Protein Subunit VaccinesIBA 03/2020
1	Prothrombin (Factor II)IBA 01/2017
1	Complement C5 (Complement 5)IBA 01/2017
1	Thrombin FDA Link 01/2017
1	Superoxides (Superoxide)IBA 01/2017
1	Biological ProductsIBA 04/2015
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 04/2015
1	Culture MediaIBA 10/2014
1	Peptide Hydrolases (Proteases)FDA Link 10/2014
1	Basic Amino Acids (Basic Amino Acid)IBA 10/2014
1	Complement System Proteins (Complement)IBA 10/2014
1	Matrix Metalloproteinases (MMPs)IBA 04/2013
1	matrigelIBA 04/2013
1	Anaphylatoxin C5a ReceptorIBA 04/2013
1	AndrogensIBA 11/2012
1	Thromboplastin (Tissue Factor)IBA 11/2012
1	Tranexamic Acid (AMCA)FDA Link 11/2012
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 11/2012
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 11/2012
1	FibrinIBA 11/2012
1	Prostate-Specific Antigen (Semenogelase)IBA 11/2012
1	fibrinmonomerIBA 11/2012
1	antithrombin III-protease complexIBA 11/2012
1	Fibrinolysin FDA Link 11/2012
1	fosfestrol (Kyorin)FDA Link 11/2012
1	CollagenIBA 03/2011

Therapy/Procedure

3	Therapeutics 12/2021 - 11/2012
1	Stents 07/2022
1	Lasers (Laser) 07/2022
1	Nephrectomy 05/2019
1	Castration 11/2012